Company intelligence / Profile preview
Serum Institute of India
Pune, Maharashtra, Indiaseruminstitute.com ↗
- Ownership
- Private
- Employees
- ~7000
- Development stage
- Commercial
01
Overview
Serum Institute of India manufactures over three billion doses annually across more than two dozen WHO-prequalified vaccines covering all major childhood immunizations and several adult/preventive indications. Its products are widely used in global immunization programs run by WHO/UNICEF/PAHO/GAVI. The company played a pivotal role during the COVID‑19 pandemic with Covishield™—the Oxford/AstraZeneca vaccine manufactured under license—and continues to expand its portfolio with new launches such as R21 malaria vaccine and indigenous HPV vaccine Cervavac.
- Therapeutic areas
- OtherOncologyInfectious Diseases
- Modalities
- Vaccines (recombinant, conjugate, live attenuated, inactivated)Monoclonal antibodies (e.g., Rabies Human Monoclonal Antibody)Antisera
- Industry
- Pharma
02
Drug pipeline
58 assets57 more assets in the full pipeline.
Request access →03
Partnerships
University of Oxford/AstraZeneca/Covax for COVID‑19 vaccine production (“Covishield”)CEPI partnership for rapid outbreak response/vaccine development networkPATH/MenAfriVac project/Bill & Melinda Gates Foundation/National Institutes of Health on various affordable global health vaccinesUNICEF/GAVI supply partnerships
Beyond the preview
Go deeper on Serum Institute of India.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Serum Institute of India.